InvestorsHub Logo
Followers 104
Posts 2500
Boards Moderated 0
Alias Born 12/02/2016

Re: stervc post# 43938

Thursday, 09/21/2017 4:13:26 PM

Thursday, September 21, 2017 4:13:26 PM

Post# of 94131
Comprehensive $TXTM DD package Sterling, well done. Thank you for taking the time to retrieve and compile this important DD.

What I've understood after listening to last week's Parliament hearing, is that South Africa has gone through much of the due process, and is consequently now positioned to reschedule/down-schedule cannabis within the next few weeks.

https://drive.google.com/file/d/0B4WJojoiFSszTVE5UERWdFAxWmc/view

Upon the SA governmental ratification, according to the founder of SACCRA Jason Sean O'Donoghue, Plandai SA/Protext Pharma is expected to "gain access" to a research and development license that will allow for the company to employ its proprietary technology to produce a pharmaceutical grade non-psychoactive cannabis product under license from America. IMO, the implications of South Africa down-scheduling cannabis are profound for $TXTM. It will be interesting to see what unfolds over the next few weeks.